These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
873 related articles for article (PubMed ID: 29604467)
1. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467 [TBL] [Abstract][Full Text] [Related]
2. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model. Yeo S; Lim S Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771 [TBL] [Abstract][Full Text] [Related]
3. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse. Song LK; Ma KL; Yuan YH; Mu Z; Song XY; Niu F; Han N; Chen NH PLoS One; 2015; 10(6):e0131281. PubMed ID: 26114655 [TBL] [Abstract][Full Text] [Related]
4. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related]
5. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model. Yeo S; Song J; Lim S Adv Exp Med Biol; 2020; 1232():401-408. PubMed ID: 31893437 [TBL] [Abstract][Full Text] [Related]
6. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model. Heo EJ; Lee Y; Hyung Seo M; Yeo S Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811 [TBL] [Abstract][Full Text] [Related]
7. Geraniol attenuates α-synuclein expression and neuromuscular impairment through increase dopamine content in MPTP intoxicated mice by dose dependent manner. Rekha KR; Selvakumar GP; Santha K; Inmozhi Sivakamasundari R Biochem Biophys Res Commun; 2013 Nov; 440(4):664-70. PubMed ID: 24103762 [TBL] [Abstract][Full Text] [Related]
8. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease. Mariucci G; Pagiotti R; Galli F; Romani L; Conte C J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201 [TBL] [Abstract][Full Text] [Related]
9. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
10. Decrease in Han S; Seo MH; Lim S; Yeo S Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylated α-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP. Huang B; Wu S; Wang Z; Ge L; Rizak JD; Wu J; Li J; Xu L; Lv L; Yin Y; Hu X; Li H Neuroscience; 2018 May; 379():302-315. PubMed ID: 29592843 [TBL] [Abstract][Full Text] [Related]
12. Seo MH; Yeo S Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502283 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP Wu KC; Liou HH; Lee CY; Lin CJ Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389 [TBL] [Abstract][Full Text] [Related]
14. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease. Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678 [TBL] [Abstract][Full Text] [Related]
15. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice. Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273 [TBL] [Abstract][Full Text] [Related]
16. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor. Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864 [TBL] [Abstract][Full Text] [Related]
17. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Kowall NW; Hantraye P; Brouillet E; Beal MF; McKee AC; Ferrante RJ Neuroreport; 2000 Jan; 11(1):211-3. PubMed ID: 10683860 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. Dong Z; Ferger B; Feldon J; Büeler H J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578 [TBL] [Abstract][Full Text] [Related]
19. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease. Lv Z; Jiang H; Xu H; Song N; Xie J J Neural Transm (Vienna); 2011 Mar; 118(3):361-9. PubMed ID: 20556443 [TBL] [Abstract][Full Text] [Related]
20. Association of increase in Serping1 level with dopaminergic cell reduction in an MPTP-induced Parkinson's disease mouse model. Seo MH; Yeo S Brain Res Bull; 2020 Sep; 162():67-72. PubMed ID: 32485229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]